Circulating endothelial cells as biomarkers of prostate cancer

被引：0
|
作者：
Harry D Georgiou
Benjamin Namdarian
Niall M Corcoran
Anthony J Costello
Christopher M Hovens
机构：
[1] Royal Melbourne Hospital.,HD Georgiou is an Advanced Medical Science Trainee in the Department of Surgery
[2] Royal Melbourne Hospital.,B Namdarian is a Urology Trainee with the Urological Society of Australia and New Zealand and is also a PhD candidate in the Department of Urology and Surgery
[3] NM Corcoran is a Urology Trainee with the Urological Society of Australia and New Zealand,and a Urology Clinical Research Fellow in the Department of Urology and Surgery
[4] Royal Melbourne Hospital.,AJ Costello is a Professorial Fellow and Head of the Department of Urology, affiliated with the Department of Surgery
[5] The Royal Melbourne Hospital,Departments of Urology and Surgery
[6] University of Melbourne.,undefined
[7] CM Hovens is Director of the Prostate Cancer Research Center,undefined
[8] Royal Melbourne Hospital,undefined
[9] University of Melbourne,undefined
[10] Australia.,undefined
来源：
Nature Clinical Practice Urology | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Prostate cancer has a wide spectrum of biological aggressiveness, but characterization of prostate-cancer aggressiveness at the time of diagnosis can be difficult. Tumor vascularization positively correlates with disease progression and, therefore, markers of angiogenesis could be indicators of clinical outcomes. Circulating endothelial progenitors and circulating endothelial cells play an integral part in neovascularization, and in this Review the authors discuss the potential of these cells as prognostic indicators.
引用
收藏
页码：445 / 454
页数：9
相关论文
共 50 条
  • [1] Circulating endothelial cells as biomarkers of prostate cancer
    Georgiou, Harry D.
    Namdarian, Benjamin
    Corcoran, Niall M.
    Costello, Anthony J.
    Hovens, Christopher M.
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (08): : 445 - 454
  • [2] THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER
    Namdarian, B.
    Georgiou, H. D.
    Chua, J.
    Chin, X.
    Hong, M. K. H.
    Costello, A. J.
    Corcoran, N. M.
    Hovens, C. M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 143 - 143
  • [3] Biomarkers: Circulating tumor cells in prostate cancer
    Groves-Kirkby N.
    [J]. Nature Reviews Urology, 2009, 6 (5) : 238 - 238
  • [4] Circulating Tumor Cells as Biomarkers in Prostate Cancer
    Danila, Daniel C.
    Fleisher, Martin
    Scher, Howard I.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (12) : 3903 - 3912
  • [5] Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers
    Reeves, Fairleigh
    Sapre, Nikhil
    Corcoran, Niall
    Hovens, Christopher
    [J]. BIOMARKERS IN MEDICINE, 2013, 7 (06) : 879 - 891
  • [6] Circulating endothelial cells and their subsets: novel biomarkers for cancer
    Zhou, Fangbin
    Zhou, Yaying
    Dong, Jun
    Tan, Wenyong
    [J]. BIOMARKERS IN MEDICINE, 2017, 11 (08) : 665 - 676
  • [7] CIRCULATING ENDOTHELIAL CELLS: A NEW BIOMARKER IN PROSTATE CANCER
    Namdarian, Benjamin
    Georgiou, Harry
    Corcoran, Niall
    Hovens, Christopher
    Costello, Anthony
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E827 - E827
  • [8] Circulating biomarkers for prostate cancer
    Thomas Steuber
    Pauliina Helo
    Hans Lilja
    [J]. World Journal of Urology, 2007, 25 : 111 - 119
  • [9] Circulating biomarkers for prostate cancer
    Steuber, Thomas
    Helo, Pauliina
    Lilja, Hans
    [J]. WORLD JOURNAL OF UROLOGY, 2007, 25 (02) : 111 - 119
  • [10] Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer
    Gorin, Michael A.
    Verdone, James E.
    van der Toom, Emma
    Bivalacqua, Trinity J.
    Allaf, Mohamad E.
    Pienta, Kenneth J.
    [J]. NATURE REVIEWS UROLOGY, 2017, 14 (02) : 90 - 97
12345